Multiple equity analyst upgrades across semiconductor, software, and biotech sectors

Several major financial institutions, including Raymond James and Morgan Stanley, have issued upgrades and price target increases for various U.S.-listed equities. These adjustments reflect shifting analyst sentiment regarding valuation and growth prospects for companies such as AMD, Dynatrace, and Summit Therapeutics.